Cited by 2,287Pregnancy and preeclampsia studiesNeurological Complications and SyndromesNeonatal and fetal brain pathology

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia

Open access

Rolnik, Daniel L., Wright, David, Poon, Liona C., O’Gorman, Neil, Syngelaki, Argyro, de Paco Matallana, Catalina, Akolekar, Ranjit, Cicero, Simona, Janga, Deepa, Singh, Mandeep, Molina, Francisca S., Persico, Nicola, Jani, Jacques C., Plasencia, Walter, Papaioannou, George, Tenenbaum-Gavish, Kinneret, Meiri, Hamutal, Gizurarson, Sveinbjorn, Maclagan, Kate, Nicolaides, Kypros H.·2017·New England Journal of Medicine

DOI 10.1056/nejmoa1704559

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Preterm preeclampsia is an important cause of maternal and perinatal death and complications. It is uncertain whether the intake of low-dose aspirin during pregnancy reduces the risk of preterm preeclampsia. METHODS: In this multicenter, double-blind, placebo-controlled trial, we randomly assigned 1776 women with singleton pregnancies who were at high risk for preterm preeclampsia to receive aspirin, at a dose of 150 mg per day, or placebo from 11 to 14 weeks of gestation until 36 weeks of gestation. The primary outcome was delivery with preeclampsia before 37 weeks of gestation. The analysis was performed according to the intention-to-treat principle. RESULTS: A total of 152 women withdrew consent during the trial, and 4 were lost to follow up, which left 798 participants in the aspirin group and 822 in the placebo group. Preterm preeclampsia occurred in 13 participants (1.6%) in the aspirin group, as compared with 35 (4.3%) in the placebo group (odds ratio in the aspirin group, 0.38; 95% confidence interval, 0.20 to 0.74; P=0.004). Results were materially unchanged in a sensitivity analysis that took into account participants who had withdrawn or were lost to follow-up. Adherence was good, with a reported intake of 85% or more of the required number of tablets in 79.9% of the participants. There were no significant between-group differences in the incidence of neonatal adverse outcomes or other adverse events. CONCLUSIONS: Treatment with low-dose aspirin in women at high risk for preterm preeclampsia resulted in a lower incidence of this diagnosis than placebo. (Funded by the European Union Seventh Framework Program and the Fetal Medicine Foundation; EudraCT number, 2013-003778-29 ; Current Controlled Trials number, ISRCTN13633058 .).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa1704559

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Untitled work
(2013) · doi:10.1097/01.aog.0000437382.03963.88 · Cited by 3,961
The Global Impact of Pre-eclampsia and Eclampsia
Duley, L. (2009) · Seminars in Perinatology · doi:10.1053/j.semperi.2009.02.010 · Cited by 2,866
THE CLASSIFICATION AND DIAGNOSIS OF THE HYPERTENSIVE DISORDERS OF PREGNANCY: STATEMENT FROM THE INTERNATIONAL SOCIETY FOR THE STUDY OF HYPERTENSION IN PREGNANCY (ISSHP)
Brown, M. A., Lindheimer, M. D., de Swiet, M., Assche, A. V., & Moutquin, J. (2001) · Hypertension in Pregnancy · doi:10.1081/prg-100104165 · Cited by 1,894
A CRITICAL EVALUATION OF SONAR “CROWN‐RUMP LENGTH” MEASUREMENTS
Robinson, H. P., & Fleming, J. E. E. (1975) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1975.tb00710.x · Cited by 1,413
The Classification and Diagnosis of the Hypertensive Disorders of Pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP)
Brown, M. A., Lindheimer, M. D., de SWIET, M., et al. (2001) · Hypertension in Pregnancy · doi:10.3109/10641950109152635 · Cited by 1,369
Prevention of Preeclampsia and Intrauterine Growth Restriction With Aspirin Started in Early Pregnancy
Bujold, E., Roberge, S., Lacasse, Y., Bureau, M., Audibert, F., Marcoux, S., Forest, J., & Giguère, Y. (2010) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3181e9322a · Cited by 1,112
Long term mortality of mothers and fathers after pre-eclampsia: population based cohort studyPre-eclampsia and cardiovascular disease later in life: who is at risk?
Irgens, H. U., Roberts, J. M., Reisæter, L., Irgens, L. M., & Lie, R. T. (2001) · BMJ · doi:10.1136/bmj.323.7323.1213 · Cited by 1,040
Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data
Askie, L. M., Duley, L., Henderson-Smart, D. J., & Stewart, L. A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60712-0 · Cited by 1,025
Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease
Lisonkova, S., & Joseph, K. S. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.08.019 · Cited by 926
The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis
Roberge, S., Nicolaides, K., Demers, S., Hyett, J., Chaillet, N., & Bujold, E. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.09.076 · Cited by 679
Self-citation

Flagged first, then by citations

Show all 24 references

Research works printed but not linked: 2

National Collaborating Centre for Women’s and Children’s Health (UK). Hypertension in pregnancy: the management of hypertensive disorders during pregnancy. London: RCOG Press, 2010.
Van Buuren S, 2011, J Stat Softw, 45, 1

Sorted by citations

Items 401–500 of 1,002

Stroke in Pregnancy
Camargo, E. C., Feske, S. K., & Singhal, A. B. (2018) · Neurologic Clinics · doi:10.1016/j.ncl.2018.09.010 · Cited by 36
Performance of first‐trimester combined screening for preterm pre‐eclampsia: findings from cohort of 10 110 pregnancies in Spain
Cuenca-Gómez, D., Matallana, C. D. P., Rollé, V., Valino, N., Revello, R., Adiego, B., Mendoza, M., Molina, F. S., Carrillo, M. P., Delgado⋈, J. L., et al. (2023) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.26233 · Cited by 35
Self-citation
Association between adverse pregnancy outcome and placental biomarkers in the first trimester: A prospective cohort study
Sovio, U., Gaccioli, F., Cook, E., Jones, D. S., & Smith, G. C. S. (2023) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.17691 · Cited by 35
Immunologic aspects of preeclampsia
Boulanger, H., Bounan, S., Mahdhi, A., Drouin, D., Ahriz-Saksi, S., Guimiot, F., & Rouas‐Freiss, N. (2024) · AJOG Global Reports · doi:10.1016/j.xagr.2024.100321 · Cited by 35
Phenotypes of maternal vascular malperfusion placental pathology and adverse pregnancy outcomes: A retrospective cohort study
Zur, R. L., McLaughlin, K., Aalto, L., Jiang, Y., Huszti, E., Parks, W. T., & Kingdom, J. C. (2024) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.17837 · Cited by 35
External validation of preexisting first trimester preeclampsia prediction models
Allen, R. E., Zamora, J., Arroyo-Manzano, D., Velauthar, L., Allotey, J., Thangaratinam, S., & Aquilina, J. T. (2017) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2017.08.031 · Cited by 35
First‐trimester and combined first‐ and second‐trimester prediction of small‐for‐gestational age and late fetal growth restriction
Sotiriadis, A., Figueras, F., Eleftheriades, M. I., Papaioannou, G., Chorozoglou, G., Dinas, K. D., & Papantoniou, N. E. (2018) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.19055 · Cited by 35
Self-citation
Prediction of preterm birth with and without preeclampsia using mid-pregnancy immune and growth-related molecular factors and maternal characteristics
Jelliffe‐Pawlowski, L. L., Rand, L., Bedell, B. A., Baer, R. J., Oltman, S. P., Norton, M. E., Shaw, G. M., Stevenson, D. K., Murray, J. C., & Ryckman, K. K. (2018) · Journal of Perinatology · doi:10.1038/s41372-018-0112-0 · Cited by 35
Pregnancy Outcomes in Systemic Vasculitides
Ross, C., D'Souza, R. D., & Pagnoux, C. (2020) · Current Rheumatology Reports · doi:10.1007/s11926-020-00940-5 · Cited by 35
ASPRE trial: risk factors for development of preterm pre‐eclampsia despite aspirin prophylaxis
Shen, L., Martinez-Portilla, R. J., Rolnik, D. L., & Poon, L. C. (2021) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.23668 · Cited by 35
Self-citation
STATIN trial: predictive performance of competing‐risks model in screening for pre‐eclampsia at 35–37 weeks' gestation
Döbert, M., Wright, A., Varouxaki, A.-N., Mu, A. C., Syngelaki, A., Rehal, A., Delgado⋈, J. L., Akolekar, R., Muscettola, G., JANGA, D., et al. (2021) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.24789 · Cited by 35
Self-citation
First-Trimester Screening for Fetal Growth Restriction and Small-for-Gestational-Age Pregnancies without Preeclampsia Using Cardiovascular Disease-Associated MicroRNA Biomarkers
Hromadníková, I., Kotlabová, K., & Krofta, L. (2022) · Biomedicines · doi:10.3390/biomedicines10030718 · Cited by 36
Guía de práctica clínica de la Sociedad Interamericana de Cardiología sobre prevención primaria de enfermedad cardiovascular en la mujer
Sueldo, M. D., Rivera, M. A. M., Sanchez-Zambrano, M. B., Zilberman, J. M., Múnera, A. G., Paniagua, M., Campos-Alcántara, L., Almonte, C., Paix-Gonzales, A., Anchique-Santos, C. V., et al. (2022) · Archivos de cardiología de México · doi:10.24875/acm.22000071 · Cited by 40
Preeclampsia and Long-term Renal Function in Women Who Underwent Kidney Transplantation
Vannevel, V., Claes, K. J., Baud, D., Vial, Y., Golshayan, D., Yoon, E. W., Hodges, R. J., Nepveu, A. L., Kerr, P. G., Kennedy, C., et al. (2017) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000002404 · Cited by 35
Regulators of G protein signaling in cardiovascular function during pregnancy
Perschbacher, K. J., Deng, G., Fisher, R. A., Gibson-Corley, K. N., Santillan, M. K., & Grobe, J. L. (2018) · Physiological Genomics · doi:10.1152/physiolgenomics.00037.2018 · Cited by 36
Biology of preeclampsia: Combined actions of angiogenic factors, their receptors and placental proteins
Huppertz, B. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.11.024 · Cited by 35
Protective effect of metformin on a rat model of lipopolysaccharide‐induced preeclampsia
Hu, J., Zhang, J., & Zhu, B. (2019) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12501 · Cited by 35
Care of late intrauterine fetal death and stillbirth
Burden, C., Merriel, A., Bakhbakhi, D., Heazell, A. E. P., & Siassakos, D. M. (2024) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.17844 · Cited by 34
Molecular subtyping of hypertensive disorders of pregnancy
Elovitz, M. A., Gee, E. P. S., Delaney-Busch, N., Moe, A. B., Reddy, M., Khodursky, A. B., La, J., Abbas, I., Mekaru, K., Collins, H., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58157-y · Cited by 34
An external exposome-wide association study of hypertensive disorders of pregnancy
Hu, H. Z., Zhao, J., Savitz, D. A., Prosperi, M., Zheng, Y., & Pearson, T. A. (2020) · Environment International · doi:10.1016/j.envint.2020.105797 · Cited by 35
Good clinical practice advice: First trimester screening and prevention of pre‐eclampsia in singleton pregnancy
FIGO Working Group on Good Clinical Practice in Maternal–Fetal Medicine (2019) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12741 · Cited by 34
Reducing health inequality in Black, Asian and other minority ethnic pregnant women: impact of first trimester combined screening for placental dysfunction on perinatal mortality
Liu, B., Nadeem, U., Frick, A., Alakaloko, M., Bhidé, A., & Thilaganathan, B. (2022) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.17109 · Cited by 34
Headache in Pregnancy
Robbins, M. S. (2018) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000642 · Cited by 34
Comparison of different methods of first‐trimester screening for preterm pre‐eclampsia: cohort study
Cuenca-Gómez, D., Matallana, C. D. P., Rollé, V., Mendoza, M., Valino, N., Revello, R., Adiego, B., Pedraz, C. C., Molina, F. S., Delgado⋈, J. L., et al. (2024) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.27622 · Cited by 33
Self-citation
Antioxidant Properties of Albumin and Diseases Related to Obstetrics and Gynecology
Watanabe, K., Kinoshita, H., Okamoto, T., Sugiura, K., Kawashima, S., & Kimura, T. (2025) · Antioxidants · doi:10.3390/antiox14010055 · Cited by 33
Women and kidney health: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Piccoli, G. B., Ahmed, S. B., Fakhouri, F., Garovic, V. D., Hladunewich, M., Jesudason, S., Prakash, J., Webster, A. C., Zakharova, E., Cheung, M., et al. (2025) · Kidney International · doi:10.1016/j.kint.2025.02.021 · Cited by 38
Early screening and prevention of preterm pre‐eclampsia with aspirin: time for clinical implementation
Rolnik, D. L., O’Gorman, N., Roberge, S., Bujold, E., Hyett, J. A., Uzan, S., Beaufils, M., & Costa, F. D. S. (2017) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.18899 · Cited by 33
Self-citation
Aspirin versus placebo in pregnancies at high risk for preterm pre-eclampsia
Story, L., & Nelson‐Piercy, C. (2018) · Obstetric Medicine · doi:10.1177/1753495x18775898 · Cited by 33
Preeclampsia induced by STOX1 overexpression in mice induces intrauterine growth restriction, abnormal ultrasonography and BOLD MRI signatures
Collinot, H., Marchiol, C., Lagoutte, I., Lager, F., Siauve, N., Autret, G., Balvay, D., Renault, G., Salomon, L. J., & Vaiman, D. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001695 · Cited by 33
Decidual Vasculopathy Identification in Whole Slide Images Using Multiresolution Hierarchical Convolutional Neural Networks
Clymer, D. R., Kostadinov, S., Catov, J. M., Skvarca, L. B., Pantanowitz, L., Cagan, J., & LeDuc, P. R. (2020) · American Journal Of Pathology · doi:10.1016/j.ajpath.2020.06.014 · Cited by 33
Determinants of preterm survival in a tertiary hospital in Ghana: A ten-year review
Agbeno, E. K., Osarfo, J., Ashong, J., Anane‐Fenin, B., Okai, E., Ofori, A. A., Mohammed, A., Opoku, D. A., Ken‐Amoah, S., Ashong, J., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0246005 · Cited by 33
Aggrephagy Deficiency in the Placenta: A New Pathogenesis of Preeclampsia
Nakashima, A., Shima, T., Tsuda, S., Aoki, A., Kawaguchi, M., Furuta, A., Yasuda, I., Yoneda, S., Yamaki‐Ushijima, A., Cheng, S., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052432 · Cited by 35
Potentially modifiable risk factors of preterm delivery in women with type 1 and type 2 diabetes
Søholm, J. C., Vestgaard, M. J., Ásbjörnsdóttir, B., Do, N. C., Pedersen, B. W., Storgaard, L., Nielsen, B. B., Ringholm, L., Damm, P., & Mathiesen, E. R. (2021) · Diabetologia · doi:10.1007/s00125-021-05482-8 · Cited by 33
Pre-eclampsia: a Scoping Review of Risk Factors and Suggestions for Future Research Direction
Lee, K., Brayboy, L. M., & Tripathi, A. (2022) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-021-00243-w · Cited by 33
Machine Learning to Predict Pre-Eclampsia and Intrauterine Growth Restriction in Pregnant Women
Gómez-Jemes, L., Oprescu, A. M., Chimenea, Á., García‐Díaz, L., & Ternero, M. D. C. R. (2022) · Electronics · doi:10.3390/electronics11193240 · Cited by 33
Parental ethnicity and placental maternal vascular malperfusion pathology in healthy nulliparous women
Audette, M. C., Levytska, K., Lye, S. J., Melamed, N., & Kingdom, J. C. (2018) · Placenta · doi:10.1016/j.placenta.2018.04.014 · Cited by 33
Current and emerging pharmacotherapy for emergency management of preeclampsia
Langston‐Cox, A., Marshall, S. A., Palmer, K. R., & Wallace, E. M. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1570134 · Cited by 33
Reviewing Accuracy of First Trimester Screening for Preeclampsia Using Maternal Factors and Biomarkers
Malone, S. L., Haj Yahya, R., & Kane, S. C. (2022) · International Journal of Women's Health · doi:10.2147/ijwh.s283239 · Cited by 32
Low-dose aspirin prevents LPS-induced preeclampsia-like phenotype via AQP-1 and the MAPK/ERK 1/2 pathway
Zhang, J., Jing, S., Zhang, H., Zhang, J., Xie, H., & Feng, L. (2022) · Placenta · doi:10.1016/j.placenta.2022.03.007 · Cited by 32
A Balancing Act: Navigating Hypertensive Disorders of Pregnancy at Very Advanced Maternal Age, from Preconception to Postpartum
Lopian, M., Ligumsky, L. K., & Many, A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12144701 · Cited by 33
Use of medication in pregnancy on the rise: Study on 1.4 million Danish pregnancies from 1998 to 2018
Thunbo, M. Ø., Vendelbo, J. H., Witte, D. R., Larsen, A., & Pedersen, L. H. (2024) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.14805 · Cited by 32
Nanomedicine as a potential approach to empower the new strategies for the treatment of preeclampsia
Valéro, L., Alhareth, K., Gil, S., Lecarpentier, É., Tsatsaris, V., Mignet, N., Fournier, T., & Andrieux, K. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.01.048 · Cited by 32
Prophylaxis and treatment of foetal growth restriction
Nawathe, A. R., & David, A. L. (2018) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2018.02.007 · Cited by 32
Maternal right ventricular function, uteroplacental circulation in first trimester and pregnancy outcome in women with congenital heart disease
Siegmund, A. S., Kampman, M. A. M., Oudijk, M. A., Mulder, B. J. M., Sieswerda, G. T., Koenen, S. V., Hummel, Y. M., de Laat, M. W. M., Sollie-Szarynska, K. M., Groen, H., et al. (2018) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.20148 · Cited by 32
Pre-pregnancy or first-trimester risk scoring to identify women at high risk of preterm birth
Baer, R. J., McLemore, M. R., Adler, N. E., Oltman, S. P., Chambers, B. D., Kuppermann, M., Pantell, M. S., Rogers, E. E., Ryckman, K. K., Sirota, M., et al. (2018) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2018.11.004 · Cited by 32
Actualización en preeclampsia
Calvo, J. P., Rodríguez, Y. P., & Figueroa, L. Q. (2020) · Revista Medica Sinergia · doi:10.31434/rms.v5i1.340 · Cited by 32
Adverse perinatal outcome and placental abnormalities in pregnancies with major fetal congenital heart defects: A retrospective case‐control study
Giorgione, V., Fesslová, V., Boveri, S., Candiani, M., Khalil, A. A., & Cavoretto, P. I. (2020) · Prenatal Diagnosis · doi:10.1002/pd.5770 · Cited by 32
Family History of Hypertension, Cardiovascular Disease, or Diabetes and Risk of Developing Preeclampsia: A Systematic Review
Kay, V. R., Wedel, N., & Smith, G. N. (2020) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2020.08.010 · Cited by 32
Sulforaphane Bioavailability and Effects on Blood Pressure in Women with Pregnancy Hypertension
Langston‐Cox, A., Anderson, D., Creek, D. J., Palmer, K. R., Marshall, S. A., & Wallace, E. M. (2021) · Reproductive Sciences · doi:10.1007/s43032-020-00439-5 · Cited by 32
Infertility, Infertility Treatment, and Cardiovascular Disease: An Overview
Smith, J., Vélez, M. P., & Dayan, N. (2021) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2021.09.002 · Cited by 32
Preeclampsia: a report and recommendations of the workshop of the Society for Maternal-Fetal Medicine and the Preeclampsia Foundation
Louis, J. M., Parchem, J. G., Vaught, A. “. J., Tesfalul, M. A., Kendle, A. M., & Tsigas, E. Z. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2022.06.038 · Cited by 33
Preeclampsia: Narrative Review for Clinical Use
Gracia, P. V., Vargas, C., Sánchez, J., & Cubas, J. A. C. (2022) · Heliyon · doi:10.1016/j.heliyon.2023.e14187 · Cited by 36
Body mass index and the risk of hypertensive disorders of pregnancy: the great obstetrical syndromes (GOS) study
Gasse, C., Boutin, A., Demers, S., Chaillet, N., & Bujold, E. (2017) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2017.1399117 · Cited by 32
The epidemic of abnormal copy number variant cases missed because of reliance upon noninvasive prenatal screening
Evans, M. I., Andriole, S., Curtis, J., Evans, S. M., Kessler, A. A., & Rubenstein, A. F. (2018) · Prenatal Diagnosis · doi:10.1002/pd.5275 · Cited by 32
Pulmonary Hypertension in Pregnancy: Challenges and Solutions
Afify, H. M. A., Kong, A., Bernal, J., & Elgendy, I. Y. (2022) · Integrated Blood Pressure Control · doi:10.2147/ibpc.s242242 · Cited by 32
Preeclampsia at term: evidence of disease heterogeneity based on the profile of circulating cytokines and angiogenic factors
Chaiworapongsa, T., Romero, R. J., Gomez‐Lopez, N., Suksai, M., Gallo, D. M., Jung, E., Berry, S. M., Awonuga, A. O., Tarca, A. L., & Bryant, D. R. (2023) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2023.10.002 · Cited by 32
Midpregnancy Placental Growth Factor Screening and Early Preterm Birth
Gladstone, R. A., Ahmed, S., Huszti, E., McLaughlin, K., Snelgrove, J. W., Taher, J., Hobson, S. R., Windrim, R. C., Murphy, K. E., & Kingdom, J. C. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.44454 · Cited by 31
Management of idiopathic recurrent pericarditis during pregnancy
Brucato, A. L., Pluymaekers, N. A. H. A., Tombetti, E., Rampello, S., Maestroni, S., Lucianetti, M., Valenti, A., Adler, Y., & Imazio, M. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.02.003 · Cited by 31
Aspirin facilitates trophoblast invasion and epithelial-mesenchymal transition by regulating the miR-200-ZEB1 axis in preeclampsia
Su, M., Tsai, P., Wang, C., Tsai, H.-L., & Kuo, P. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111591 · Cited by 31
Association of family history with incidence and gestational hypertension outcomes of preeclampsia
Wu, C.-T., Kuo, C., Lin, C., Huang, Y., Chen, S., Wu, H., & Chu, P. (2021) · International Journal of Cardiology Hypertension · doi:10.1016/j.ijchy.2021.100084 · Cited by 31
Preeclampsia and postpartum mental health: mechanisms and clinical implications
Srajer, A., Johnson, J.-A., & Yusuf, K. (2021) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2021.1978067 · Cited by 31
Trends and outcomes for deliveries with hypertensive disorders of pregnancy from 2000 to 2018: A repeated cross‐sectional study
Wen, T., Schmidt, C. N., Sobhani, N. C., Guglielminotti, J. R., Miller, E. C., Sutton, D. M., Lahtermaher, Y., D’Alton, M. E., & Friedman, A. M. (2021) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.17038 · Cited by 33
Low-dose asprin use during pregnancy may be a potential risk for postpartum hemorrhage and increased blood loss: a systematic review and meta-analysis
Jiang, Y., Chen, Z., Chen, Y., Wei, L., Gao, P., Zhang, J., Zhou, X., Zhu, S., Zhang, H., Du, Y., et al. (2023) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2023.100878 · Cited by 31
Preeclampsia and Long-Term Risk of Venous Thromboembolism
Havers‐Borgersen, E., Butt, J. H., Johansen, M., Petersen, O. B., Ekelund, C. K., Rode, L., Olesen, J. B., Køber, L., & Fosbøl, E. L. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.43804 · Cited by 31
First trimester serum afamin concentrations are associated with the development of pre-eclampsia and gestational diabetes mellitus in pregnant women
Tramontana, A., Dieplinger, B., Stangl, G., Hafner, E., & Dieplinger, H. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.11.031 · Cited by 31
Preeclampsia as a Form of Type 5 Cardiorenal Syndrome: An Underrecognized Entity in Women’s Cardiovascular Health
Rangaswami, J., Naranjo, M., & McCullough, P. A. (2018) · Cardiorenal Medicine · doi:10.1159/000487646 · Cited by 31
Pregnancy outcomes in nulliparous women with positive first-trimester preterm preeclampsia screening test: the Great Obstetrical Syndromes cohort study
Boutin, A., Guerby, P., Gasse, C., Tapp, S., & Bujold, E. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.08.008 · Cited by 32
Volume and vascularity: Using ultrasound to unlock the secrets of the first trimester placenta
Mathewlynn, S., & Collins, S. L. (2019) · Placenta · doi:10.1016/j.placenta.2019.06.379 · Cited by 30
Preeclampsia and aspirin
Ahn, T. G., & Hwang, J. Y. (2023) · Obstetrics & Gynecology Science · doi:10.5468/ogs.22261 · Cited by 31
Pre‐eclampsia in low and middle‐income settings: What are the barriers to improving perinatal outcomes and evidence‐based recommendations?
Mayrink, J., & Reis, Z. S. N. (2023) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.14913 · Cited by 30
Predictive performance of sFlt-1, PlGF and the sFlt-1/PlGF ratio for preeclampsia: A systematic review and meta-analysis
Zhang, L., Li, W., Chi, X., Sun, Q., Li, Y., Xing, W., & Ding, G. (2025) · Journal of Gynecology Obstetrics and Human Reproduction · doi:10.1016/j.jogoh.2025.102925 · Cited by 31
Mitochondrial DNA Copy Number in Peripheral Blood in the First Trimester of Pregnancy and Different Preeclampsia Clinical Phenotypes Development: A Pilot Study
Busnelli, A., Lattuada, D., Ferrari, S., Reschini, M., Colciaghi, B., Somigliana, E., Fedele, L., & Ferrazzi, E. M. (2018) · Reproductive Sciences · doi:10.1177/1933719118804410 · Cited by 31
Inter-manufacturer comparison of automated immunoassays for the measurement of soluble FMS-like tyrosine kinase-1 and placental growth factor
Cheng, Y. K. Y., Poon, L. C., Shennan, A. H., Leung, T. Y., & Sahota, D. S. (2019) · Pregnancy Hypertension · doi:10.1016/j.preghy.2019.06.004 · Cited by 30
Self-citation
Alpha-1 microglobulin as a potential therapeutic candidate for treatment of hypertension and oxidative stress in the STOX1 preeclampsia mouse model
Erlandsson, L., Ducat, A., Castille, J., Zia, I., Kalapotharakos, G., Hedström, E., Vilotte, J.-L., Vaiman, D., & Hansson, S. R. (2019) · Scientific Reports · doi:10.1038/s41598-019-44639-9 · Cited by 30
Type 2 Diabetes in Pregnancy
Kapur, A., McIntyre, D. H., & Hod, M. (2019) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.05.009 · Cited by 30
Prediction of Preeclampsia in Nulliparous Women according to First Trimester Maternal Factors and Serum Markers
Pihl, K., Sørensen, S., & Jørgensen, F. S. (2019) · Fetal Diagnosis and Therapy · doi:10.1159/000503229 · Cited by 30
Disruption of Placental Homeostasis Leads to Preeclampsia
Nakashima, A., Shima, T., Tsuda, S., Aoki, A., Kawaguchi, M., Yoneda, S., Yamaki‐Ushijima, A., Cheng, S., Sharma, S., & Saito, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093298 · Cited by 31
Prediction of preeclampsia risk in first time pregnant women: Metabolite biomarkers for a clinical test
Kenny, L. C., Thomas, G. R., Poston, L., Myers, J., Simpson, N., McCarthy, F. P., Brown, L. W., Bond, A. E., Tuytten, R., & Baker, P. N. (2020) · PLoS ONE · doi:10.1371/journal.pone.0244369 · Cited by 30
Phenotype‐Directed Management of Hypertension in Pregnancy
McLaughlin, K., Snelgrove, J. W., Sienas, L. E., Easterling, T. R., Kingdom, J. C., & Albright, C. M. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.023694 · Cited by 30
Screening for preeclampsia in twin pregnancies
Francisco, C., Gamito, M., Reddy, M., & Rolnik, D. L. (2022) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2022.03.008 · Cited by 30
Self-citation
Assessment of adherence to aspirin for preeclampsia prophylaxis and reasons for nonadherence
Olson, D. N., Russell, T., & Ranzini, A. C. (2022) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2022.100663 · Cited by 30
Low-dose aspirin treatment enhances the adhesion of preeclamptic decidual mesenchymal stem/stromal cells and reduces their production of pro-inflammatory cytokines
Khanabdali, R., Shakouri‐Motlagh, A., Wilkinson, S., Murthi, P., Georgiou, H. M., Brennecke, S. P., & Kalionis, B. (2018) · Journal of Molecular Medicine · doi:10.1007/s00109-018-1695-9 · Cited by 30
Women’s Reproductive Health for the Nephrologist
Burgner, A. M., & Hladunewich, M. (2019) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2019.04.017 · Cited by 30
Maternal Stroke
Elgendy, I. Y., Bukhari, S., Barakat, A. F., Pepine, C. J., Lindley, K. J., & Miller, E. C. (2021) · Circulation · doi:10.1161/circulationaha.120.051460 · Cited by 68
Prediction of pre-eclampsia with machine learning approaches: Leveraging important information from routinely collected data
Tiruneh, S. A., Rolnik, D. L., Teede, H. J., & Enticott, J. (2024) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2024.105645 · Cited by 31
Self-citation
Pregnancy and the liver
Rahim, M. N., Williamson, C., Kametas, N. A., & Heneghan, M. A. (2025) · The Lancet · doi:10.1016/s0140-6736(24)02351-1 · Cited by 29
Cerebral palsy and obstetric-neonatological interventions
Młodawski, J., Młodawska, M., Pazera, G., Michalski, W., Domański, T., Dolecka-Ślusarczyk, M., Głuszek, S., & Rokitaⴕ, W. (2019) · Ginekologia Polska · doi:10.5603/gp.2019.0124 · Cited by 29
Recurrent implantation failure – an overview of current research
Günther, V., von Otte, S., Freytag, D., Maass, N., & Alkatout, İ. (2021) · Gynecological Endocrinology · doi:10.1080/09513590.2021.1878136 · Cited by 29
Routine first‐trimester combined screening for pre‐eclampsia: pregnancy‐associated plasma protein‐A or placental growth factor?
Noël, L., Guy, G. P., Jones, S., Forenc, K. M., Buck, E., Papageorghiou, A. T., & Thilaganathan, B. (2021) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.23669 · Cited by 29
Effective Aspirin Treatment of Women at Risk for Preeclampsia Delays the Metabolic Clock of Gestation
Li, X., Milosavljevic, A., Elsea, S. H., Wang, C. C., Scaglia, F., Syngelaki, A., Nicolaides, K. H., & Poon, L. C. (2021) · Hypertension · doi:10.1161/hypertensionaha.121.17448 · Cited by 29
Self-citation
Management of type 2 diabetes in pregnancy: a narrative review
Raets, L., Ingelbrecht, A., & Benhalima, K. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1193271 · Cited by 31
Managing migraine in pregnancy
Jarvis, S., Dassan, P., & Nelson‐Piercy, C. (2018) · BMJ · doi:10.1136/bmj.k80 · Cited by 29
Increased incidence of obstetric and perinatal complications in pregnancies achieved using donor oocytes and single embryo transfer in young and healthy women. A prospective hospital-based matched cohort study
Rodriguez‐Wallberg, K. A., Berger, A.-S., Fagerberg, A., Olofsson, J. I., Scherman-Pukk, C., Lindqvist, P. G., & Nasiell, J. (2019) · Gynecological Endocrinology · doi:10.1080/09513590.2018.1528577 · Cited by 29
Effect of Low-Dose Aspirin on Soluble FMS-Like Tyrosine Kinase 1/Placental Growth Factor (sFlt-1/PlGF Ratio) in Pregnancies at High Risk for the Development of Preeclampsia
Mayer-Pickel, K. I., Kolovetsiou-Kreiner, V., Stern, C., Münzker, J., Eberhard, K., Trajanoski, S., Lakovschek, I.-C., Ulrich, D., Csapó, B., Lang, U., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8091429 · Cited by 30
Role of sFlt-1 and PlGF in the screening of small-for-gestational age neonates during pregnancy: A systematic review
Hendrix, M., Bons, J. A. P., van Haren, A., van Kuijk, S. M. J., van Doorn, W., Kimenai, D. M., Bekers, O., Spaanderman, M. E. A., & Al‐Nasiry, S. (2019) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563219882042 · Cited by 31
Quality assessment of uterine artery Doppler measurement in first‐trimester combined screening for pre‐eclampsia
Rolnik, D. L., Costa, F. D. S., Sahota, D. S., Hyett, J. A., & McLennan, A. (2018) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.19116 · Cited by 28
Self-citation
The Transforming Growth Factor β Superfamily As Possible Biomarkers of Preeclampsia: A Comprehensive Review
Adu‐Gyamfi, E. A., Lamptey, J., Duan, F.-M., Wang, Y., & Ding, Y. (2019) · Biomarkers in Medicine · doi:10.2217/bmm-2019-0208 · Cited by 28
Screening for preeclampsia in low‐risk twin pregnancies at early gestation
Chen, J., Zhao, D. P., Liu, Y., Zhou, J., Zou, G., Zhang, Y., Guo, M., Duan, T., Mieghem, T. V., & Sun, L. (2020) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.13890 · Cited by 28
Management of Autosomal Dominant Polycystic Kidney Disease (ADPKD) During Pregnancy: Risks and Challenges
McBride, L., Wilkinson, C., & Jesudason, S. (2020) · International Journal of Women s Health · doi:10.2147/ijwh.s204997 · Cited by 28
Artificially prepared vitrified–warmed embryo transfer cycles are associated with an increased risk of pre-eclampsia
Roelens, C., Racca, A., Mackens, S., Landuyt, L. V., Buelinckx, L., Gucciardo, L., Tournaye, H. J., Vos, M. D., & Blockeel, C. (2021) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2021.12.004 · Cited by 29

Authors: Rolnik, D. L., Wright, D., Poon, L. C., O’Gorman, N., Syngelaki, A., de Paco Matallana, C., Akolekar, R., Cicero, S., Janga, D., Singh, M., Molina, F. S., Persico, N., Jani, J. C., Plasencia, W., Papaioannou, G., Tenenbaum-Gavish, K., Meiri, H., Gizurarson, S., Maclagan, K., & Nicolaides, K. H.
Affiliations: Université Libre de Bruxelles (BE)
King's College Hospital (GB)
ORCID: Rolnik, Daniel L.
Wright, David
Poon, Liona C.
O’Gorman, Neil
Syngelaki, Argyro
Akolekar, Ranjit
Singh, Mandeep
Molina, Francisca S.
Persico, Nicola
Jani, Jacques C.
Plasencia, Walter
Papaioannou, George
Meiri, Hamutal
Maclagan, Kate
Nicolaides, Kypros H.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2017-08-17
Volume: 377
Issue: 7
Pages: 613-622
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa1704559
OpenAlex: W2730504020
Cited by: 2,287
References: 24
Citations by year: 2026: 252 · 2025: 277 · 2024: 231 · 2023: 274 · 2022: 257 · 2021: 249 · 2020: 265 · 2019: 212 · 2018: 196 · 2017: 69
FWCI: 238.94
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Research Portal (King's College London) (publishedVersion, other-oa)
Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
RISalud Institutional Health Repository of Andalucía (submittedVersion, other-oa)
Funders: Imperial College London
Imperial College Healthcare NHS Trust
University College London
European Commission (FP7-HEALTH-2013INNOVATION, 601852, HEALTH-2013)
Fetal Medicine Foundation
FP7 Health (601852)
Topics: Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
Health Sciences › Medicine › Clinical Neurology › Neurological Complications and Syndromes
Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal and fetal brain pathology
Keywords: low-dose aspirin, preterm preeclampsia, high-risk pregnancy, preeclampsia prevention, singleton pregnancy, drug safety in pregnancy, adverse neonatal outcomes
MeSH terms: Adult, Aspirin, Double-Blind Method, Female, Humans, Infant, Newborn, Pre-Eclampsia, Pregnancy, Pregnancy Complications, Pregnancy Outcome, Risk, Incidence, Kaplan-Meier Estimate, Intention to Treat Analysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks